Jw Pharmac (Korea) Analysis
001060 Stock | 23,250 250.00 1.06% |
Jw Pharmac is overvalued with Real Value of 20958.0 and Hype Value of 23250.0. The main objective of Jw Pharmac stock analysis is to determine its intrinsic value, which is an estimate of what Jw Pharmac is worth, separate from its market price. There are two main types of Jw Pharmac's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Jw Pharmac's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Jw Pharmac's stock to identify patterns and trends that may indicate its future price movements.
The Jw Pharmac stock is traded in Korea on Korea Stock Exchange, with the market opening at 09:00:00 and closing at 15:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Jw Pharmac's ongoing operational relationships across important fundamental and technical indicators.
001060 |
001060 Stock Analysis Notes
About 43.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 28th of December 2022. Jw Pharmac had 1:1 split on the 25th of December 2023. For more info on Jw Pharmac please contact YoungSub Shin at 82 2 840 6777 or go to https://www.jw-pharma.co.kr.Jw Pharmac Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Jw Pharmac's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Jw Pharmac or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Jw Pharmac generated a negative expected return over the last 90 days | |
The company reported the revenue of 606.58 B. Net Loss for the year was (967.85 M) with profit before overhead, payroll, taxes, and interest of 234.38 B. | |
About 43.0% of the company shares are owned by insiders or employees |
001060 Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 478.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jw Pharmac's market, we take the total number of its shares issued and multiply it by Jw Pharmac's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.001060 Profitablity
Jw Pharmac's profitability indicators refer to fundamental financial ratios that showcase Jw Pharmac's ability to generate income relative to its revenue or operating costs. If, let's say, Jw Pharmac is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Jw Pharmac's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Jw Pharmac's profitability requires more research than a typical breakdown of Jw Pharmac's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07. Technical Drivers
As of the 5th of December, Jw Pharmac owns the Information Ratio of (0.16), coefficient of variation of (1,060), and Market Risk Adjusted Performance of (0.88). Jw Pharmac technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.Jw Pharmac Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Jw Pharmac middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Jw Pharmac. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Jw Pharmac Outstanding Bonds
Jw Pharmac issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Jw Pharmac uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most 001060 bonds can be classified according to their maturity, which is the date when Jw Pharmac has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
International Game Technology Corp BondUS460599AD57 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Jw Pharmac Predictive Daily Indicators
Jw Pharmac intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Jw Pharmac stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 1677.64 | |||
Daily Balance Of Power | (0.33) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 23425.0 | |||
Day Typical Price | 23366.67 | |||
Market Facilitation Index | 0.0141 | |||
Price Action Indicator | (300.00) | |||
Period Momentum Indicator | (250.00) | |||
Relative Strength Index | 37.73 |
Jw Pharmac Forecast Models
Jw Pharmac's time-series forecasting models are one of many Jw Pharmac's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Jw Pharmac's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Jw Pharmac to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
All Next | Launch Module |
Complementary Tools for 001060 Stock analysis
When running Jw Pharmac's price analysis, check to measure Jw Pharmac's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jw Pharmac is operating at the current time. Most of Jw Pharmac's value examination focuses on studying past and present price action to predict the probability of Jw Pharmac's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jw Pharmac's price. Additionally, you may evaluate how the addition of Jw Pharmac to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |